Form 4 for ADMA ADMA BIOLOGICS, INC.
Accepted 2025-06-11 00:00:00 ET · period of report 2025-06-09 · accession 0001140361-25-022240 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-06-11 | 2025-06-09 | ADMA | Guiheen Lawrence P. | Dir | S - Sale | $20.96 | -20.0K | 94.8K | -17% | -$419.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-06-09 | S | D | 20,000 | $20.96 | 94,830 | D | — | — | (F1) Includes, as of the transaction date, (i) 10,889 restricted stock units granted on February 19, 2025, which vest in two equal installments, on the six- and 12-month anniversaries of the grant date, becoming fully vested on the one-year anniversary of the grant date, subject to the Reporting Person's continued service as of such vesting date; and (ii) 83,941 shares of common stock owned by the Reporting Person. |